Impact of Cell-surface Antigen Expression on Target Engagement and Function of an Epidermal Growth Factor Receptor ×

Stephen W Jarantow1, Barbara S Bushey1, Jose R Pardinas1

  • 1From Janssen Research and Development, LLC, Spring House, Pennsylvania 19477 and.

Insights

Bispecific antibodies (BsAbs) efficacy depends on target protein levels. This study shows BsAb JNJ-61186372 binding favors higher expressed targets (EGFR/c-MET), enhancing potency against lower expressed targets.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Bispecific antibodies (BsAbs) engage multiple targets, but efficacy is influenced by relative cell-surface protein levels.
  • Understanding target receptor density is crucial for optimizing BsAb therapy.

Purpose of the Study:

  • To correlate receptor density with the in vitro activity of a BsAb targeting epidermal growth factor receptor (EGFR) and hepatocyte growth factor receptor (c-MET).
  • To investigate the binding bias of BsAbs towards differentially expressed cell-surface receptors.

Main Methods:

  • Utilized controlled Fab-arm exchange to generate BsAbs targeting EGFR and c-MET.
  • Quantified EGFR and c-MET receptor density in lung and gastric cancer cell lines.
  • Correlated receptor density with gene expression and phosphorylation inhibition.

Main Results:

  • Confirmed simultaneous binding of BsAb JNJ-61186372 to EGFR and c-MET in vitro.
  • Observed BsAb binding bias towards the more highly expressed receptor (EGFR or c-MET).
  • Demonstrated enhanced in vitro potency against the less highly expressed target.

Conclusions:

  • Proposed an avidity model for BsAb engagement of EGFR and c-MET.
  • Highlighted implications for bispecific drug efficacy and design based on receptor expression levels.